Lupin Limited (LUPIN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lupin Limited (LUPIN) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs29.03 Billion ≈ $313.93 Million USD) by net assets (Rs197.28 Billion ≈ $2.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Lupin Limited's balance sheet to measure how much of total assets are equity-financed.
Lupin Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Lupin Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Lupin Limited to evaluate the quality of earnings relative to operating cash generation.
Lupin Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lupin Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HDFC Asset Management Company Limited
NSE:HDFCAMC
|
0.130x |
|
Washington H Soul Pattinson & Company Ltd
AU:SOL
|
-0.041x |
|
Allegro.eu S.A.
WAR:ALE
|
0.012x |
|
TAISEI CORP. ADR/ 1/4
F:TKK
|
N/A |
|
SON.HO.UN.ADR 1/5 SF -05
F:PHBA
|
N/A |
|
Jeronimo Martins SGPS SA
LS:JMT
|
0.198x |
|
DT Midstream Inc
NYSE:DTM
|
0.060x |
|
Avery Dennison Corp
NYSE:AVY
|
0.141x |
Annual Cash Flow Conversion Efficiency for Lupin Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Lupin Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see LUPIN stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs172.94 Billion ≈ $1.87 Billion |
Rs30.00 Billion ≈ $324.43 Million |
0.173x | -31.66% |
| 2024-03-31 | Rs143.73 Billion ≈ $1.55 Billion |
Rs36.48 Billion ≈ $394.56 Million |
0.254x | +67.83% |
| 2023-03-31 | Rs125.43 Billion ≈ $1.36 Billion |
Rs18.97 Billion ≈ $205.15 Million |
0.151x | +403.24% |
| 2022-03-31 | Rs122.22 Billion ≈ $1.32 Billion |
Rs3.67 Billion ≈ $39.72 Million |
0.030x | -77.14% |
| 2021-03-31 | Rs138.58 Billion ≈ $1.50 Billion |
Rs18.22 Billion ≈ $197.02 Million |
0.131x | +12.60% |
| 2020-03-31 | Rs125.81 Billion ≈ $1.36 Billion |
Rs14.69 Billion ≈ $158.85 Million |
0.117x | -3.37% |
| 2019-03-31 | Rs137.89 Billion ≈ $1.49 Billion |
Rs16.66 Billion ≈ $180.17 Million |
0.121x | -6.05% |
| 2018-03-31 | Rs136.17 Billion ≈ $1.47 Billion |
Rs17.51 Billion ≈ $189.38 Million |
0.129x | -57.69% |
| 2017-03-31 | Rs135.32 Billion ≈ $1.46 Billion |
Rs41.14 Billion ≈ $444.86 Million |
0.304x | +1022.36% |
| 2016-03-31 | Rs111.95 Billion ≈ $1.21 Billion |
Rs-3.69 Billion ≈ $-39.90 Million |
-0.033x | -110.73% |
| 2015-03-31 | Rs88.98 Billion ≈ $962.30 Million |
Rs27.33 Billion ≈ $295.57 Million |
0.307x | +7.27% |
| 2014-03-31 | Rs69.99 Billion ≈ $756.86 Million |
Rs20.04 Billion ≈ $216.72 Million |
0.286x | +20.48% |
| 2013-03-31 | Rs52.64 Billion ≈ $569.24 Million |
Rs12.51 Billion ≈ $135.29 Million |
0.238x | +73.36% |
| 2012-03-31 | Rs40.85 Billion ≈ $441.80 Million |
Rs5.60 Billion ≈ $60.57 Million |
0.137x | -42.67% |
| 2011-03-31 | Rs33.33 Billion ≈ $360.41 Million |
Rs7.97 Billion ≈ $86.18 Million |
0.239x | -8.32% |
| 2010-03-31 | Rs25.93 Billion ≈ $280.46 Million |
Rs6.76 Billion ≈ $73.15 Million |
0.261x | -20.06% |
| 2009-03-31 | Rs14.39 Billion ≈ $155.63 Million |
Rs4.70 Billion ≈ $50.78 Million |
0.326x | +62.70% |
| 2008-03-31 | Rs12.89 Billion ≈ $139.41 Million |
Rs2.59 Billion ≈ $27.96 Million |
0.201x | -1.57% |
| 2007-03-31 | Rs8.73 Billion ≈ $94.45 Million |
Rs1.78 Billion ≈ $19.24 Million |
0.204x | -8.77% |
| 2006-03-31 | Rs5.89 Billion ≈ $63.68 Million |
Rs1.32 Billion ≈ $14.22 Million |
0.223x | +18.37% |
| 2005-03-31 | Rs4.91 Billion ≈ $53.05 Million |
Rs925.60 Million ≈ $10.01 Million |
0.189x | -79.18% |
| 2004-03-31 | Rs4.32 Billion ≈ $46.67 Million |
Rs3.91 Billion ≈ $42.29 Million |
0.906x | -- |
About Lupin Limited
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutica… Read more